A review of the mechanisms of ventricular arrhythmia in Brugada syndrome

Indian Pacing and Electrophysiology Journal

Volumn 10, Issue 9, 2010, Pages 410-425

  Bhar Amato, J ^a   Nunn, L M ^a   Lambiase, P D ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Brugada syndrome, ventricular arrhyhthmia, right ventricular outflow tract, depolarisation, repolarisation, transmural gradient, sodium channel

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM ION; CONNEXIN 43; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; POTASSIUM CHANNEL KCNE3; QUINIDINE; SODIUM CHANNEL; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ARRHYTHMOGENESIS; AUTONOMIC NERVOUS SYSTEM FUNCTION; BRUGADA SYNDROME; DEFIBRILLATION; DISEASE ASSOCIATION; DISEASE MARKER; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; EMBRYO DEVELOPMENT; EXCITATION CONTRACTION COUPLING; HEART DEATH; HEART DEPOLARIZATION; HEART DEVELOPMENT; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE CONDUCTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IN VIVO STUDY; J POINT ELEVATION; LOSS OF FUNCTION MUTATION; NONHUMAN; POTASSIUM CURRENT; PR INTERVAL; QRS COMPLEX; REVIEW; SODIUM CHANNELOPATHY; SODIUM CURRENT; ST SEGMENT ELEVATION; T WAVE INVERSION; TISSUE DOPPLER IMAGING;

EID: 78751479282     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. Journal of the American College of Cardiology1992;20:1391-6.
2. Wilde A, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation2002;106:2514-9.
3. Atarashi H, Ogawa S, Harumi K, et al. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads. Journal of the American College of Cardiology2001;37:1916-20.
4. Hermida J, Lemoine J, Aoun F, Jarry G, Rey J, Quiret J. Prevalence of the Brugada syndrome in an apparently healthy population. American Journal of Cardiology2000;86:91-4.
5. Nagase S, Fukushima-Kusano K, Morita H, et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome. Journal of the American College of Cardiology2002;39:1992-5.
6. Morita H, Kusano K, Nagase S. Site-specific arrhythmogenesis in patients with Brugada syndrome. Journal of cardiovascular electrophysiology2003;14:373-9.
7. Takagi M, Aihara N, Kuribayashi S, et al. Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with Brugada syndrome. European Heart Journal 2001;22:1032-41.
8. Eckardt L, Kirchhof P, Schulze-Bahr E, et al. Electrophysiologic investigation in Brugada syndrome. Yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. European Heart Journal2002;23:1394-401.
9. Häissaguerre M, Extramiana F, Meleze H, et al Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation2003;108:925-8.
10. Eckardt I, Bruns H, Paul M, et al. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. Journal of cardiovascular electrophysiology2002;13:742-9.
11. Nagase S, Fukushima-Kusano K, Morita H, et al Longer repolarisation in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome. Journal of the American College of Cardiology2008;51:1154-61.
12. Takami M, Ikeda T, Enjoji Y, Sugi K. Relationship between ST segment morphology and conduction disturbances detected by signal-averaged electrocardiography in Brugada syndrome. Annals of Non-Invasive Electrocardiology2003;8:30-6.
13. Boukens B, Christoffels V, Coronel R, Moorman A. Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate to life threatening arrhythmias. Circulation Research2009;104:19-31.
14. Hutson M, Kirby M. Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Seminal Cell Developmental Biology2007;18:101-10.
15. Jongbloed M, Schalij M, Poelmann R, et al. Embryonic conduction tissue: a spatial correlation with adult arrhythmogenic areas. Journal of cardiovascular electrophysiology2004;15:349-55.
16. Ou B, Nakagawa M, Kajimoto M, et al. Heterogenous expression of connexin 43 in the myocardium of right ventricular outflow tract. Life Sciences2005;77:52-9.
17. Peters N, Coromilas J, Severs N, Wit A. Disturbed connexin 43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventriuclar tachycardia. Circulation1997;95:988-96.
18. Meregalli P, Wilde A, Tan H. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovascular Research2005;67:367-78.
19. Coronel R, Casini S, Koopmann T, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic and computational study. Circulation2005;112:2769-77.
20. Kurita T, Shimizu W, Inagaki M, et al. The electrophysiologic mechanism of ST segment elevation in Brugada syndrome. Journal of the American College of Cardiology2002;40:330-4.
21. Liu D, Gintant G, Antzelevitch C. Ionic bases for electrophysiological distinctions among epicardial, midmyocardial and endocardial myocytes from the free wall of the canine left ventricle. Circulation Research1993;72:671-87.
22. Di Diego J, Cordeiro J, Goodrow R, et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation2002;106:204-2011.
23. Antzelevitch C. The Brugada syndrome: Ionic basis and arrhythmia mechanisms. Journal of cardiovascular electrophysiology2001;12:268-72.
24. Ailings M, Dekker L, Sadee A, Wilde A. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clinical Electrophysiology2001;24:1420-2.
25. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation2004;110:1731-7.
26. Watanabe A, Chiniushi M, Washizuka T, et al. Variable electrocardiographic effects of shortterm quinidine sulfate administration in Brugada syndrome. Pacing Clinical Electrophysiology2005;28:372-7.
27. Gaborit N, Wichter T, Varro A, et al Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases. European Heart Journal2009;30:487-96.
28. Thomsen P, Joergensen R, Kanters J, et al. Phase 2 reentry in man. Heart Rhythm2005;2:797-803.
29. Antzelevitch C. Late potentials and the Brugada syndrome (Editorial comment). Journal of the American College of Cardiology2002;39(12):1996-9.
30. Kakashita M, Kurita T, Matsuo K, et al Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. Journal of the American College of Cardiology2000;36:1646-53.
31. Kasanuki H, Ohnishi S, Ohtuka M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation1997;95:2277-85.
32. Kanda M, Shimizu W, Matsuo K, et al. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. Journal of the American College of Cardiology2002;39:1799-805.
33. Tukkie R, Segaard P, Vleugels J, et al. Delay in right ventricular activation contributes to Brugada syndrome. Circulation2004;109:1272-7.
34. Postema P, van Dessel P, de Bakker J, et al Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study. Circulation2008;1:379-86.
35. Postema PG, Kors JA et al. Local depolarisation abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in Brugada syndrome. Journal of the American College of Cardiology2010;55:789-97.
36. Lambiase P, Ahmed A, Ciaccio E, et al. High density substrate mapping in Brugada syndrome -combined role of conduction and repolarisation heterogeneities in arrhythmogenesis. Circulation2008;120:106-17.
37. Morita H, Fukushima-Kusano K, Miura D, et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation2008;118:1697-704.
38. Smits J, Eckardt I, Probst V, et al. Genotype-Phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. Journal of the American College of Cardiology2002;40:350-6.
39. Chen Q, Kirsch G, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature1998;392:293-6.
40. London B, Michales M, Haider M, et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene decreases cardiac Na+ current and causes inherited arrhythmias. Circulation2007;116:2260-8.
41. Antzelevitch C, Pollevick G, Cordeiro J, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST segment elevation, short QT intervals, and sudden cardiac death. Circulation2007;115:442-9.
42. Delpon E, Cordeiro J, Nunez L, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circulation: Arrhythmia and Electrophysiology 2009;1:209-18.
43. Killeen M, Thomas G, Sabir I, et al Mouse models of human arrhythmia syndromes. Acta Physiologica2008;192:455-69.
44. Sabir I, Li L, Jones V, et al. Criteria for arrhythmogenicity in genetically modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome. European Journal of Physiology2008;455:637-51.
45. Catalano O, Antonaci S, Moro G, et al. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. European Heart Journal2009;30:2241-8.
46. Papavassiliu T, Wolpert C, Fluchter S, et al. Magnetic resonance imaging findings in patients with Brugada syndrome. Journal of cardiovascular electrophysiology2004;15:1133-8.
47. Hoogendijk M, Opthof T, Postema P, et al. The Brugada ECG Pattern: A Marker of Channelopathy, Structural Heart Disease, or Neither? Circ Arrhythm Electrophysiol 2010;3:283-90.
48. Crotti L, Spazzolini C, Schwartz P, et al. The common Long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds. Circulation2007;116:2366-75.
49. Hoogendijk M, Potse M, Linnenbank A, et al. Mechanism of right praecordial ST segment elevation in structural heart disease: excitation failure by current-to-load mismatch. Heart Rhythm2010;7:238-48.
50. Peters S, Trümmel M, Denecke S, Koehler B. Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy. International Journal of Cardiology2004;95:207-10.
51. Zumhagen S, Spieker T, Rolinck J, et al. Absence of pathognomonic or inflammatory patterns in cardiac biopsies from patients with Brugada syndrome. Circulation: Arrhythmia and Electrophysiology2009;2:16-23.
52. Frustaci A, Priori S, Pieroni M, et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation2005;112(24):3680-7.
53. Corrado D, Nava A, Gianfranco B, et al. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. Journal of the American College of Cardiology1996;27(2):443-8.
54. Watanabe A, Fukushima-Kusano F, Morita H, et al. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome. European Heart Journal2006;27:1579-83.
55. Maury P, Couderc P, Delay M, Boveda S, Brugada J. Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace2004;6:130-3.
56. Mizumaki K, Fujiki A, Tsuneda T, et al. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. Journal of cardiovascular electrophysiology2004;15:667-73.
57. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrythmic drug modulation of ST segment elevation in patients with Brugada syndrome. Journal of the American College of Cardiology1996;27(5):1061-70.
58. Babaee Bigi M, Asiani A, Aslani A. Significance of cardiac autonomic neuropathy in risk stratification of Brugada syndrome. Europace2008;10:821-4.
59. Wichter T, Matheja P, Eckardt L, et al. Cardiac autonomic dysfunction in Brugada syndrome. Circulation2002;105:702-6.
60. Kies P, Wichter T, Schafers M, et al. Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome. Circulation2004;110:3017-22.
61. Litovsky S, Antzelevitch C. Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylycholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. Circulation Research1990;67:615-27.
62. Weiss J, Karma A, Shiferaw Y, et al. From pulsus to pulseless: the saga of cardiac alternans. Circulation Research2006;98:1244-53.
63. Mok N, Priori S, Napolitano C, et al. A newly characterized SCN5A mutation underlying Brugada syndrome unmasked by hyperthermia. Journal of cardiovascular electrophysiology2003;14:407-4111.
64. Keller D, Huang H, Zhao J, et al. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation. Cardiovascular Research2006;70:521-9.
65. Samani K, Wu G, Tomohiko A, et al. A novel SCN5A mutation V13401 in Brugada syndrome augmenting arrhythmias during febrile illness. Heart Rhythm2009;6(9):1318-26.
66. Dinckal M, et al. Incessant monomorphic ventricular tachycardia during febrile illness in a patient with Brugada syndrome: fatal electrical storm. Europace2003;5(3):257-61.
67. Dumaine R, Towbin J, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circulation Research1999;85:803-9.
68. Keller D, Rougier J, Kucera J, et al. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations. Cardiovascular Research2005;67:510-9.